MEDICAMEN BIOTECH
Back to Balance Sheet
|
MEDICAMEN BIOTECH Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹292 Cr | ₹277 Cr | ₹225 Cr | ₹194 Cr | ₹181 Cr |
What is the latest Total Liabilities ratio of MEDICAMEN BIOTECH ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹292 Cr |
Mar2023 | ₹277 Cr |
Mar2022 | ₹225 Cr |
Mar2021 | ₹194 Cr |
Mar2020 | ₹181 Cr |
How is Total Liabilities of MEDICAMEN BIOTECH Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹292 Cr | 5.57 | |
Mar2023 | ₹277 Cr | 22.84 | |
Mar2022 | ₹225 Cr | 16.08 | |
Mar2021 | ₹194 Cr | 7.02 | |
Mar2020 | ₹181 Cr | - |
Compare Total Liabilities of peers of MEDICAMEN BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MEDICAMEN BIOTECH | ₹546.9 Cr | -13.3% | -10% | -10.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹409,003.0 Cr | -1.6% | -4.6% | 14.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,939.0 Cr | -1.6% | -1.3% | 61.6% | Stock Analytics | |
CIPLA | ₹117,835.0 Cr | 0.1% | 1.2% | 3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,784.6 Cr | -2.1% | -8.7% | -2.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹90,722.1 Cr | -6.5% | -9.3% | 8.6% | Stock Analytics |
MEDICAMEN BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MEDICAMEN BIOTECH | -13.3% |
-10% |
-10.2% |
SENSEX | -2.5% |
-1.4% |
6.1% |
You may also like the below Video Courses